It has been previously documented that overproduction of hepatic TG-rich VLDL and decreased degradation of apolipoprotein B (apoB), a major component of VLDL, in insulin-deficient and/or resistant individuals contribute significantly to hypertriglyceridaemia [5]. The gene discussed is APOB; the disease is hypertriglyceridemia.